Well, another week has passed by and RVX and ZCC have paid Don another $12,318 in salary and no progress has been announced. Not a surprise.

Seven months from now on May 13 2023 the Hepalink debenture of $6 million USD or Cdn $8,268,000 becomes due and if not paid all of the intellectual property becomes the property of Hepalink. Hepa has the option of converting the debenture into RVX shares at a price below $.20 Cdn. That is a lot of shares for hepalink. 

The clock is ticking.

If my “Fun With Numbers” analysis was a reasonably accurate analysis of the support for Don then all of Don’s support traces to Chinese investors.

These Chinese investors control 46% of RVX stock.

All other major investors (Eastern, NGN, Protair, CD Venture and possibly including Dr Wong) abstained from voting (the “devil you know” phenomenon?).

The vast majority of retail shares were projected as voting against Don as a BOD member (little wonder).

Thus Don has left himself without a retail market that he can tap for funding of debt, salaries, expenses and funding for Covid, BoM2 and paying Eversana’s ever increases debt.

I’m wondering where the rabbit is hiding? I think that little bunny is hiding in China.

Luckily ZCC is not in this situation and they have a defacto CEO, Dr Lakhotia, that is making steady progress is building the ZE brand reputation and partnerships with the NCI and large BPs.

JMO. Good luck to all.

Toinv